In vivo feasibility of image-guided transvaginal focused ultrasound therapy for the treatment of intracavitary fibroids
Objective
To determine the feasibility of uterine tissue ablation in vivo using a transvaginal focused ultrasound applicator guided by ultrasound imaging.
Design
Randomized in vivo animal study.
Setting
Academic research environment.
Animal(s)
Healthy anesthetized sheep.
Intervention(s)
Uterine treatment location was determined using a computerized targeting system. Five sonications 10 seconds in duration and averaging 2,000 W/cm2 of focal ultrasound intensity were applied in each animal's uterus. Animals were euthanized either immediately or 2, 7, or 30 days post-treatment.
Main outcome measure(s)
Gross and microscopic analysis of the dissected uterus was used to quantitatively and qualitatively determine the ablated region and treatment side effects.
Result(s)
Treatments resulted in coagulative necrosis. Histopathological analysis showed that over 7 days, inflammatory cells appeared and smooth muscle bundles regenerated. By day 30, treated tissues healed and scar tissue formed. None of the animals showed abnormal behavior or medical problems. Complications in three animals were damage to the vaginal wall and colon, possibly due to inadequate applicator cooling and an empty bladder during treatment.
Conclusion(s)
Transvaginal image-guided high-intensity focused ultrasound has potential for treating uterine fibroids. Further safety testing of this treatment will prepare it for human use.
Key words: Uterine fibroids , leiomyoma , high-intensity focused ultrasound , image-guided therapy , ultrasound
To access this article, please choose from the options below
Financial support was received from the Whitaker Foundation, the National Institutes of Health, and the Natural Sciences and Engineering Research Council (Canada).
PII: S0015-0282(04)00983-5
doi:10.1016/j.fertnstert.2004.01.049
© 2004 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

